Skip to content

A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

A Randomized, Blinded Trial Comparing Miralax With Amitiza Pretreatment Versus Miralax With Dulcolax Pretreatment Versus Miralax Alone Without Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00953017
Enrollment
425
Registered
2009-08-06
Start date
2009-07-31
Completion date
2010-05-31
Last updated
2012-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

Efficacy of bowel cleansing, Patient tolerability, Amitiza, Dulcolax, Miralax, Colonoscopy preparation, Bowel preparation, Screening colonoscopy

Brief summary

Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparation. The tolerability of Miralax will hopefully improve patient satisfaction with colonoscopy and decrease their reluctance to be screened because of the uncomfortable taste and side effects of bowel preparation regimens.

Interventions

DRUGMiralax (PEG 3350)

Miralax 255gm bottle

DRUGAmitiza (Lubiprostone)

Amitiza 24mcg gelcap

DRUGDulcolax (Bisacodyl)

Bisacodyl 5mg tab x2

Golytely 1 gallon

Sponsors

Brooke Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adult patients referred to our clinic for average or increased risk screening for colorectal cancer

Exclusion criteria

* elevated serum creatinine (Men \>1.4mg/dL, Women \>1.3mg/dL) * previous diagnosis of congestive heart failure * history of bowel obstruction * history of solid organ transplant * current pregnancy * lactating mother * participants allergic to either polyethylene glycol (Miralax), lubiprostone (Amitiza), or bisacodyl (Dulcolax)

Design outcomes

Primary

MeasureTime frameDescription
The Cleanliness of the Prep as Measured by the Ottawa Scalemeasured at the time of colonoscopyBowel cleansing was evaluated with the Ottawa bowel preparation scale by each endoscopist during the endoscopy. Neither the endoscopist nor the endoscopy nurse was aware of the bowel preparation used prior to the colonoscopy. The Ottawa bowel preparation scale is a validated tool and was used in this study to provide a reliable quality assessment of the bowel preparation used for colonoscopy. This validated scale rates each section of the colon, the right, the mid, and the rectosigmoid colon, on a 5-point scale (0-4), as well as a global 3-point rating for overall colonic fluid (0-2). The total score ranges from 0 to 14. An excellent preparation with little fluid would score 0-3, a good preparation 4-6, while scores higher than 7 would indicate progressively worsening bowel preparations. A completely unprepared colon would score 11-14, depending on the amount of colonic fluid.

Secondary

MeasureTime frameDescription
Procedure Timemeasured at the time of colonoscopytotal colonoscopy procedure time
Polyps Detectedmeasured at the time of colonoscopyNumber of polyps
Patient Satisfaction With the Prep Measured by 5 Point Likert Scalemeasured at check in to colonoscopypatient satisfaction based on a Likert Scale from 0-5 (5 being completely satisfied and 0 being not satisfied)

Countries

United States

Participant flow

Recruitment details

All pateints were recruited and enrolled at Brooke Army Medical Center in San Antonio, TX from July 1, 2009 to July 1, 2010.

Pre-assignment details

NO significant events occured prior to study participant enrollment.

Participants by arm

ArmCount
Miralax Plus Amitiza
106 patients randomized to Miralax plus Amitiza will take one 24mcg gelcap of Amitiza at noon the day prior to their colonoscopy. On the day prior to the colonoscopy, the patients will mix 255gm of Miralax with 64 oz. of Gatorade and drink 32 oz. of the solution at 4 p.m. The remaining 32 oz. of the solution will be completed the morning of the procedure, approximately 4-6 hours prior to the scheduled start time of the colonoscopy.
106
Miralax Plus Dulcolax
107 patients randomized to Miralax plus Dulcolax will take two 5mg tablets of Dulcolax at noon the day prior to their colonoscopy. On the day prior to the colonoscopy, the patients will mix 255gm of Miralax with 64 oz. of Gatorade and drink 32 oz. of the solution at 4 p.m. The remaining 32 oz. of the solution will be completed the morning of the procedure, approximately 4-6 hours prior to the scheduled start time of the colonoscopy.
107
Miralax
106 patients will mix 255gm of Miralax with 64 oz. of Gatorade and drink 32 oz. of the solution at 4 p.m. The remaining 32 oz. of the solution will be completed the morning of the procedure, approximately 4-6 hours prior to the scheduled start time of the colonoscopy.
106
Golytely (Polyethylene Glycol)
106 patients will take 1 gallon of golytley (Polyethylene glycol) and drink 1/2 of the solution at 4 p.m. The remaining 1/2 of the solution will be completed the morning of the procedure, approximately 4-6 hours prior to the scheduled start time of the colonoscopy
106
Total425

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyBrown stool prior to procedure0010
Overall StudyDId not show up for colonoscopy4454
Overall StudyIncomplete data1100
Overall StudyProcedure incomplete due to pain/looping0101

Baseline characteristics

CharacteristicMiralax Plus DulcolaxMiralaxMiralax Plus AmitizaGolytely (Polyethylene Glycol)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants2 Participants2 Participants4 Participants
Age, Categorical
Between 18 and 65 years
107 Participants106 Participants104 Participants104 Participants421 Participants
Age Continuous53.8 years
STANDARD_DEVIATION 5.4
54.1 years
STANDARD_DEVIATION 5.3
55.4 years
STANDARD_DEVIATION 5.7
54.2 years
STANDARD_DEVIATION 6.7
54 years
STANDARD_DEVIATION 5.7
Region of Enrollment
United States
107 participants106 participants106 participants106 participants425 participants
Sex: Female, Male
Female
48 Participants54 Participants55 Participants49 Participants206 Participants
Sex: Female, Male
Male
59 Participants52 Participants51 Participants57 Participants219 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
6 / 1014 / 1016 / 1007 / 101
serious
Total, serious adverse events
0 / 1010 / 1010 / 1000 / 101

Outcome results

Primary

The Cleanliness of the Prep as Measured by the Ottawa Scale

Bowel cleansing was evaluated with the Ottawa bowel preparation scale by each endoscopist during the endoscopy. Neither the endoscopist nor the endoscopy nurse was aware of the bowel preparation used prior to the colonoscopy. The Ottawa bowel preparation scale is a validated tool and was used in this study to provide a reliable quality assessment of the bowel preparation used for colonoscopy. This validated scale rates each section of the colon, the right, the mid, and the rectosigmoid colon, on a 5-point scale (0-4), as well as a global 3-point rating for overall colonic fluid (0-2). The total score ranges from 0 to 14. An excellent preparation with little fluid would score 0-3, a good preparation 4-6, while scores higher than 7 would indicate progressively worsening bowel preparations. A completely unprepared colon would score 11-14, depending on the amount of colonic fluid.

Time frame: measured at the time of colonoscopy

ArmMeasureValue (MEAN)
Miralax Plus AmitizaThe Cleanliness of the Prep as Measured by the Ottawa Scale6.3 Ottawa Scale
Miralax Plus DulcolaxThe Cleanliness of the Prep as Measured by the Ottawa Scale6.8 Ottawa Scale
MiralaxThe Cleanliness of the Prep as Measured by the Ottawa Scale6.9 Ottawa Scale
Golytely (Polyethylene Glycol)The Cleanliness of the Prep as Measured by the Ottawa Scale5.1 Ottawa Scale
Secondary

Patient Satisfaction With the Prep Measured by 5 Point Likert Scale

patient satisfaction based on a Likert Scale from 0-5 (5 being completely satisfied and 0 being not satisfied)

Time frame: measured at check in to colonoscopy

ArmMeasureValue (MEAN)Dispersion
Miralax Plus AmitizaPatient Satisfaction With the Prep Measured by 5 Point Likert Scale3.8 units on a scaleStandard Deviation 1.1
Miralax Plus DulcolaxPatient Satisfaction With the Prep Measured by 5 Point Likert Scale4.1 units on a scaleStandard Deviation 0.8
MiralaxPatient Satisfaction With the Prep Measured by 5 Point Likert Scale4.0 units on a scaleStandard Deviation 1
Golytely (Polyethylene Glycol)Patient Satisfaction With the Prep Measured by 5 Point Likert Scale3.2 units on a scaleStandard Deviation 1
Secondary

Polyps Detected

Number of polyps

Time frame: measured at the time of colonoscopy

ArmMeasureValue (NUMBER)
Miralax Plus AmitizaPolyps Detected128 polyps
Miralax Plus DulcolaxPolyps Detected92 polyps
MiralaxPolyps Detected90 polyps
Golytely (Polyethylene Glycol)Polyps Detected101 polyps
Secondary

Procedure Time

total colonoscopy procedure time

Time frame: measured at the time of colonoscopy

ArmMeasureValue (MEAN)Dispersion
Miralax Plus AmitizaProcedure Time21.3 minutesStandard Deviation 10.2
Miralax Plus DulcolaxProcedure Time19.3 minutesStandard Deviation 8.1
MiralaxProcedure Time20 minutesStandard Deviation 9
Golytely (Polyethylene Glycol)Procedure Time18.3 minutesStandard Deviation 7.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026